Listen to The Lancet Oncology

The Lancet Oncology: April 01, 2011 01.04.2011 18:23 ↓

April issue highlights, including the latest developments of the breast Health Global Initiative(BHGI), including an interview with BHGI Director Benjamin Anderson.

The Lancet Oncology: March 01, 2011 01.03.2011 9:37 ↓

March issue highlights, including new data from the HERA trial about long-term efficacy of herceptin for early breast cancer.

The Lancet Oncology: January 31, 2011 31.01.2011 5:13 ↓

Rob Brierley with February highlights, including the prevalence of depression among cancer patients.

The Lancet Oncology: December 30, 2010 30.12.2010 9:40 ↓

January highlights, including automated verses manual cytology for detection of cervical cancers.

The Lancet Oncology: November 29, 2010 29.11.2010 4:02 ↓

December issue highlights, including mammography screening for younger women with familial breast cancer.

The Lancet Oncology: November 01, 2010 01.11.2010 4:02 ↓

November issue highlights, including an large-scale HPV genotype analysis with implications for cervical-cancer vaccine development, and the potential for discontinuation of imatinib treatment for people with chronic myeloid leukaemia.

The Lancet Oncology: October 04, 2010 04.10.2010 14:21 ↓

Includes author interview about a trial comparing sentinal-lymph-node biopsy with axillary-lymph-node dissection in breast cancer treatment.

The Lancet Oncology: September 01, 2010 01.09.2010 5:14 ↓

September issue highlights, including discussion of a possible association between hepatitis B infection and non-Hodgkin lymphoma in a Korean population.

The Lancet Oncology: August 02, 2010 02.08.2010 7:52 ↓

August issue highlights, including bevacizumab for NSCLC, and cancer issues among people with mental illness.

The Lancet Oncology: July 05, 2010 05.07.2010 10:07 ↓

Roy Herbst discusses the Zodiac trial, a phase 3 study assessing the efficacy of vandetanib for treating advanced non-small-cell lung cancer.

The Lancet Oncology: June 01, 2010 01.06.2010 11:28 ↓

Emma Grainger discusses erlotinib as maintenance treatment for lung cancer, and IGF1 and risk of breast cancer.

The Lancet Oncology: April 29, 2010 29.04.2010 12:12 ↓

The role of zoledronic acid with chemotherapy for early breast cancer and other issue highlights are discussed.

The Lancet Oncology: March 29, 2010 29.03.2010 7:02 ↓

April issue highlights, including a genome-wide association study of lung cancer for never smokers.

The Lancet Oncology: March 01, 2010 01.03.2010 4:55 ↓

March issue highlights, including hypofractionated radiotherapy for early breast cancer.

The Lancet Oncology: February 01, 2010 01.02.2010 7:27 ↓

Discussion of phase I novel targeted therapy for sarcoma.

The Lancet Oncology: January 06, 2010 06.01.2010 16:18 ↓

Emma Grainger with issue highlights and Kathy Albain discussing chemotherapy and tamoxifen for post-menopausal women with breast cancer.

The Lancet Oncology: December 01, 2009 01.12.2009 8:23 ↓

Audrey Ceschia discusses issue highlights, including impact of HIV infection on cancer risk.

The Lancet Oncology: October 29, 2009 29.10.2009 25:27 ↓

Discussion of new oncology management guidelines derived from didactic workshops at the Asia Oncology Summit 2009.

The Lancet Oncology: September 28, 2009 28.09.2009 5:27 ↓

Rob Brierley discusses an antithrombolic agent for patients receiving chemotherapy for solid tumours.

The Lancet Oncology: August 27, 2009 27.08.2009 12:44 ↓

Discussion of prostate cancer treatment, the PASSION-P trial, and a new Quackery column.

The Lancet Oncology: July 29, 2009 29.07.2009 5:46 ↓

Rob Brierley discusses sunitinib for kidney cancer, and how bureaucracy is stifling UK clinical research.

The Lancet Oncology: July 01, 2009 01.07.2009 11:34 ↓

Emma Grainger discusses bariatric surgery, weight loss, and cancer risk for obese people.

The Lancet Oncology: May 28, 2009 28.05.2009 10:42 ↓

Audrey Ceschia discusses issue highlights, including treatment for nausea and vomiting from chemotherapy.

The Lancet Oncology: April 29, 2009 29.04.2009 10:01 ↓

David Collingridge discusses research articles on prophylactic cranial irradiation for small-cell lung cancer, and the addition of temozolomide to radiotherapy for treating glioblastoma.

The Lancet Oncology: March 30, 2009 30.03.2009 5:29 ↓

Rob Brierley discusses research articles on cancer survival in England, and the potential for ovarian cancer screening.